| Impact of [11C]-Methionine PET/MRI in the Detection of Pituitary Adenomas Secreting ACTH and Causing Cushing's Disease (NCT03346954) | Hospices Civils de Lyon | 2017-12-11 |
| Collecting Information About Treatment Results for Patients With Cushing's Syndrome (NCT03364803) | Memorial Sloan Kettering Cancer Center | 2017-11-28 |
| Efficacy and Safety Evaluation of Osilodrostat in Cushing's Disease (NCT02697734) | Novartis Pharmaceuticals | 2016-10-03 |
| Assessment of Persistent Cognitive Impairment After Cure of Cushing's Disease (NCT02603653) | Institut National de la Santé Et de la Recherche Médicale, France | 2016-02-04 |
| Cushing's Disease Complications (NCT02568982) | Assistance Publique - Hôpitaux de Paris | 2015-09-21 |
| Targeted Therapy With Gefitinib in Patients With USP8-mutated Cushing's Disease (NCT02484755) | Huashan Hospital | 2015-06-01 |
| Seoul National University Pituitary Disease Cohort Study (NCT03474601) | Seoul National University Hospital | 2015-03-15 |
| Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly (NCT02060383) | Novartis Pharmaceuticals | 2014-05-23 |
| Mifepristone in Children With Refractory Cushing's Disease (NCT01925092) | Corcept Therapeutics | 2013-08-01 |
| Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies (NCT01794793) | RECORDATI GROUP | 2013-06-10 |
| Efficacy and Safety of Pasireotide Administered Monthly in Patients With Cushing's Disease (NCT01374906) | Novartis Pharmaceuticals | 2011-11-04 |
| An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease. (NCT01582061) | Novartis Pharmaceuticals | 2011-08-16 |
| Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome (NCT01371565) | Corcept Therapeutics | 2010-11-01 |
| Preoperative Bexarotene Treatment for Cushing's Disease (NCT00845351) | University of Virginia | 2008-11-01 |
| Long-term Cardiovascular Risk in Cured Cushing's Patients (NCT00881283) | Massachusetts General Hospital | 2008-09-08 |
| Study of Cabergoline in Treatment of Corticotroph Pituitary Tumor (NCT00889525) | Seth Gordhandas Sunderdas Medical College | 2007-11-01 |
| Rosiglitazone in Treating Patients With Newly Diagnosed ACTH-Secreting Pituitary Tumor (Cushing Disease) (NCT00612066) | Jonsson Comprehensive Cancer Center | 2007-04-01 |
| Safety and Efficacy of Different Dose Levels of Pasireotide in Patients With de Novo, Persistent or Recurrent Cushing's Disease (NCT00434148) | Novartis Pharmaceuticals | 2006-12-01 |